Kaman — Investor Presentation (September 2020)
24 slides from Kaman's investor presentation, Sep 10, 2020
Slide 1: Creating Tomorrow's Today Investor Presentation
Creating Tomorrow’s Today Investor Presentation
Slide 2: Forward Looking Statements
Forward Looking Statements FORWARD-LOOKING STATEMENTS This presentation includes "forward looking statements" relating to the announced transactions and future operations of the Company, which can be identified by the use of words such as “will,” “expect,” “poise,” “believe,” “plans,” “strategy,” “p
Slide 3: The transformation of the New Kaman on engineered solutions
The transformation of our business has focused the “New Kaman” on engineered solutions, driving innovation to solve our customers most complex challenges 3
Slide 4: Q2 2020 Overview
Q2 2020 Overview . Consolidated Sales up 1.8%; Organic sales* down 8.5% . Gross margins in excess of 30% and significant cost control improve profitability Financial . Adjusted EBITDA* of 13.4%, a 370 bps increase over prior year period Performance (from continuing operations) . Adjusted diluted ear
Slide 5: Diversified Portfolio
Diversified Portfolio Year-To-Date Sales up 12.9% to $385.2 million; Organic Sales* up 1.0% Actual YTD Q2 2020 Commercial, Business & General Aviation Sales Sales By End Market 29% of Total 54% Defense Boeing & Airbus 43% (Commercial Aviation)(direct and indirect) All Other 57% 29% Commercial, Busin
Slide 6: Meaningful Long Term Growth
Meaningful Long Term Growth Diverse End Market Exposure with Meaningful Long Term Growth Platform / Near Term Long Term End Markets Expectations Growth Drivers Performance on pace with Defense exposures provide stability and growth opportunities initial expectations for 2020; + Increase in sales e
Slide 7: Business Transformation Leading to Significant Cost Savings
Business Transformation Leading to Significant Cost Savings Significant Cost Savings Achieved; Additional Actions Identified Instituted Cost Savings ~$50 million of Annualized Savings Actions: • Execution on G&A Transformation Initiative • Workforce reductions and furloughs • Salary reductions acros
Slide 8: Capital Deployment Framework
Capital Deployment Framework Strong Balance Sheet and Significant Available Capital Cash available on hand; Significant capacity under No debt maturities Repaid $100 million on credit our $800M credit facility until 2024 facility in August Long Term Capital Deployment Priorities Value Creating Inves
Slide 9: Returning to our Roots
Returning to our Roots Positioned to grow as highly engineered products company 1950s 1970s 1997 2015 2020 Founded Launched Divested Expanded our Acquired Kaman Nuclear Distribution and Kaman engineered product Bal Seal for grew business Sciences offerings with the Engineering Continue to build our
Slide 10: Bal Seal Business Overview
Bal Seal Business Overview Business Description Primary Products . Manufacturer of precision springs, seals, and contacts servicing the medical Seals Springs Contacts technology, aerospace & defense and industrial markets . Offers critical, proprietary, precision components that are used in products
Slide 11: Expanded Product Portfolio Driving Future Growth
Expanded Product Portfolio Driving Future Growth Kaman sales by end market (%) + 2019 YTD Q2 2020 Meaningful sales and cost synergy opportunities Medical Medical 4% 4% 8% 9% Expanded breadth of highly engineered product offerings with complementary portfolio Leveraging Bal Seal’s proprietary m
Slide 12: Broad Range of Engineered Products Serving Diverse End Markets
Broad Range of Engineered Products Serving Diverse End Markets End Use Product Offering Differentiator Primary End Markets Characteristics Karon® Self Defense, Aerospace, Self Lubricating High Load, Low RPM Lubricating Industrial, Marine, Bearings Applications Machinable Liner Hydropower, Space Trad
Slide 13: Advanced Safe and Arm Devices
Advanced Safe and Arm Devices Broad Portfolio of Safe and Arm devices Highlight on JPF Key Programs JPF supports the U.S. Air Force and - Joint Programmable Fuze 40 Foreign militaries - Harpoon Qualified on 20 U.S. and Foreign Military Aircraft - Maverick - Tomahawk Completed Negotiations of Option
Slide 14: Opportunities for K-MAX continue to increase
Opportunities for K-MAX® continue to increase Strong Support for K-MAX® Aircraft Investing for future K-MAX® Opportunities • Aircraft meets the diverse needs of our customers Demand remains high; 1 New Aircraft Order • Construction, firefighting, logging, humanitarian, and Received in Q3 2020; Activ
Slide 15: Improving Performance on Structures Programs
Improving Performance on Structures Programs Results of Actions to Improve Performance Selected Programs Action Status Increase capacity utilization Achieved Disciplined approach to new program Achieved opportunities Improve operational efficiency Achieved Reduce facility footprint Achieved Achieved
Slide 16: Growth through Innovation
Growth through Innovation Designing new solutions to solve our customers toughest challenges Developing Next Evolving Innovative Material Continuing to evolve Generation Munition requirements of our Science for new our state-of-art Technologies: K-MAX® operators: engineered products: Technology: Hei
Slide 17: Investing for Growth
Investing for Growth Investing Across the Full Range of our Engineered Products Product Investment Status New facility to support new products for key customer Traditional Airframe Bearings Complete platforms Self Lubricating Bearings / Flexible Drive Systems Expansion to support growth and new appl
Slide 18: Premier Global Customer Base
Premier Global Customer Base 18
Slide 19: Our Manufacturing Footprint
Our Manufacturing Footprint 14 12 13 11 2 7 10 1 4 9 3 5 6 8 15 = Low cost facility 1. Foothills Ranch, CA 5. Jacksonville, FL 9. Middletown, CT 12. Rimpar, Germany Seals, Springs, and Contacts Assembly & Metallic o Safe and Arm Devices Precision miniature bearings 2. Colorado Springs, CO Structures
Slide 20: Questions
KAMAN Questions
Slide 21: Non-GAAP Reconciliations
Non-GAAP Reconciliations 21
Slide 22: Non-GAAP Reconciliation Organic Sales
Non-GAAP Reconciliation Organic Sales Organic Sales is defined as "Net Sales" less sales derived from acquisitions completed during the preceding twelve months. We believe that this measure provides management and investors with a more complete understanding of underlying operating results and trend
Slide 23: Non-GAAP Reconciliation Adjusted EBITDA from Continuing Operations
Non-GAAP Reconciliation Adjusted EBITDA from Continuing Operations Adjusted EBITDA from continuing operations is defined as earnings from continuing operations before interest, taxes, other expense (income), net, depreciation and amortization and certain items that are not indicative of the operatin
Slide 24: Non-GAAP Reconciliation Adjusted Earnings and Adjusted Diluted EPS
Non-GAAP Reconciliation Adjusted Earnings from Continuing Operations and Adjusted Diluted Earnings Per Share from Continuing Operations Adjusted Earnings from Continuing Operations and Adjusted Diluted Earnings per Share from Continuing Operations are defined as GAAP "Earnings from Continuing Operat